Selective estrogen receptor modulators: Clinical spectrum

被引：199
作者：
Cosman, F [1 ]
Lindsay, R
机构：
[1] Helen Hayes Hosp, Reg Bone Ctr, New York State Dept Hlth, W Haverstraw, NY 10993 USA
[2] Helen Hayes Hosp, Clin Res Ctr, New York State Dept Hlth, W Haverstraw, NY 10993 USA
来源：
ENDOCRINE REVIEWS | 1999年 / 20卷 / 03期
关键词：
D O I：
10.1210/er.20.3.418
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：418 / 434
页数：17
相关论文
共 186 条
[1]  
ABE O, 1991, AM J CLIN ONCOL-CANC, V14, pS40
[2]  
ALBAIN K, 1997, P AN M AM SOC CLIN, V16, pA128
[3]   ENDOCRINE EFFECTS OF THE COMBINATION OF MEGESTROL-ACETATE AND TAMOXIFEN IN THE TREATMENT OF METASTATIC BREAST-CANCER [J].
ALEXIEVAFIGUSCH, J ;
BLANKENSTEIN, MA ;
DEJONG, FH ;
LAMBERTS, SWJ .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (09) :1135-1140
[4]   CARCINOGENIC EFFECTS OF ADJUVANT TAMOXIFEN TREATMENT AND RADIOTHERAPY FOR EARLY BREAST-CANCER [J].
ANDERSSON, M ;
STORM, HH ;
MOURIDSEN, HT .
ACTA ONCOLOGICA, 1992, 31 (02) :259-263
[5]  
[Anonymous], 1992, Lancet, V339, P1
[6]  
[Anonymous], [No title captured]
[7]  
ASHFORD AR, 1988, CANCER, V61, P33, DOI 10.1002/1097-0142(19880101)61:1<33::AID-CNCR2820610107>3.0.CO
[8]  
2-I
[9]  
AUGER MJ, 1988, CANCER, V61, P1316, DOI 10.1002/1097-0142(19880401)61:7<1316::AID-CNCR2820610707>3.0.CO
[10]  
2-5
12345678910